Number of Shares
1.36 Mil
Current Holdings Value*
$34.27 Mil
% of Portfolio
2.92%
Total Estimate Gain
$40.10 Mil
% of Total Estimate Gain
9.39%

Eventide Healthcare & Life Sciences Fund's Celldex Therapeutics Inc Holding Summary

As of 2024-12-31, MUTUAL FUND SERIES TRUST held 1.36 Mil shares of Celldex Therapeutics Inc(CLDX), totaling $34.27 Mil. This investment constitutes 2.92% of their stock portfolio, and MUTUAL FUND SERIES TRUST now holds 2.04% of the outstanding Celldex Therapeutics Inc(CLDX) stock.

The initial trade took place in 2020Q2. And since then Eventide Healthcare & Life Sciences Fund has made 9 purchases of CLDX, at an average price of $32.72, for a total of 13.05 Mil shares. In addition, there have been 5 sales at an average price of $37.58 for 11.70 Mil shares. Based on historical transaction data and CLDX's current price of $20.34, Eventide Healthcare & Life Sciences Fund's estimated gain on his CLDX holdings is $40.10 Mil, reflecting a 9.39% gain to date.

Eventide Healthcare & Life Sciences Fund CLDX ($20.34) Holding Chart

Eventide Healthcare & Life Sciences Fund CLDX ($20.34) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1